Lyme disease testing uses specialized laboratory methods to detect Borrelia burgdorferi bacteria, tick-borne co-infections, and immune responses that indicate current or past infection. The challenge is that Borrelia spirochetes hide in tissues, form protective biofilms, and suppress immune responses, making detection incredibly difficult with conventional testing methods.
Standard medical practice uses a two-tier approach starting with an ELISA screening test, followed by Western blot confirmation if positive. This CDC protocol was designed for surveillance purposes, not clinical diagnosis, and misses the majority of chronic Lyme cases. The ELISA test only detects antibodies after your immune system mounts a full response, which may never happen in chronic infections where Borrelia suppresses immune function.
We use comprehensive testing panels that include IgM and IgG antibodies to multiple Borrelia strains, direct DNA detection through PCR methods, CD57 natural killer cell counts indicating immune suppression, and complete co-infection screening for Babesia, Bartonella, Ehrlichia, Anaplasma, and Rickettsia species. Florida physicians rarely consider Lyme disease, assuming it only exists in northern states. This geographical bias leaves thousands of Florida patients undiagnosed. Contact AgeRejuvenation to access testing conventional providers won't even consider.